Literature DB >> 33009566

Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.

Nicholas Chak Lam Yung1, Corine Sau Man Wong1, Joe Kwun Nam Chan1, Eric Yu Hai Chen1,2, Wing Chung Chang1,2.   

Abstract

Psychotic disorders are associated with premature mortality, but research was primarily based on Western countries and rarely examined non-affective psychoses other than schizophrenia (ONAP). This population-based cohort study investigated excess mortality in 46 896 schizophrenia and 20 651 ONAP patients between January 2006 and December 2016 in Hong Kong (HK), by estimating all-cause and cause-specific standardized mortality ratios (SMRs), and life-years lost (LYLs), a recently developed, more precise reduced life expectancy measure taking into account the illness onset (age at first-recorded diagnosis). Changes in mortality metrics over the study period were assessed. Study data were retrieved from a territory-wide medical-record database of public healthcare services to 7.5 million HK residents. Results showed that schizophrenia and ONAP patients had higher all-cause (schizophrenia: SMR: 2.49 [95% CI: 2.43-2.55]; ONAP: 2.00 [1.92-2.09]), natural-cause (1.80 [1.74-1.85]; 1.47 [1.40-1.54]), and unnatural-cause (6.97 [6.47-7.49]; 8.53 [7.61-9.52]) mortality rates than general population. Respiratory diseases, cardiovascular diseases, and cancers accounted for the majority of deaths in patient cohorts. Men and women with schizophrenia had 9.53 years and 8.07 years of excess LYLs, respectively. For ONAP, excess LYLs was 8.18 years for men and 5.44 years for women. The overall mortality gap remained similar for both patient groups over time despite their improved longevity and declined unnatural-cause mortality rates. Taken together, schizophrenia and ONAP are associated with increased premature mortality and substantially reduced lifespan in a predominantly Chinese population, with excess deaths mainly attributed to a natural cause. Persistent mortality gap highlights an urgent need for targeted interventions to improve the physical health of patients with psychotic disorders.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  life years lost; mortality; mortality gap; non-affective psychoses; population-based; schizophrenia

Year:  2021        PMID: 33009566      PMCID: PMC7965070          DOI: 10.1093/schbul/sbaa137

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  43 in total

1.  Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse?

Authors:  Thomas Munk Laursen; Oleguer Plana-Ripoll; Per Kragh Andersen; John J McGrath; Anita Toender; Merete Nordentoft; Vladimir Canudas-Romo; Annette Erlangsen
Journal:  Schizophr Res       Date:  2018-11-13       Impact factor: 4.939

2.  Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia.

Authors:  Stephen Kisely; Mark Smith; David Lawrence; Sarah Maaten
Journal:  Br J Psychiatry       Date:  2005-12       Impact factor: 9.319

3.  Excess mortality of psychiatric inpatients in Taiwan.

Authors:  W J Chen; Y J Huang; L L Yeh; H Rin; H G Hwu
Journal:  Psychiatry Res       Date:  1996-06-01       Impact factor: 3.222

4.  Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.

Authors:  Casey Crump; Marilyn A Winkleby; Kristina Sundquist; Jan Sundquist
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

5.  Principles-based medical informatics for success--how Hong Kong built one of the world's largest integrated longitudinal electronic patient records.

Authors:  Ngai-Tseung Cheung; Vicky Fung; Wing Nam Wong; Anna Tong; Antonio Sek; Andre Greyling; Nancy Tse; Hong Fung
Journal:  Stud Health Technol Inform       Date:  2007

6.  Mortality in patients with schizophrenia admitted for incident ischemic stroke: A population-based cohort study.

Authors:  Nicholas Chak Lam Yung; Corine Sau Man Wong; Joe Kwun Nam Chan; Philip Chi Fai Or; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Eur Neuropsychopharmacol       Date:  2019-12-26       Impact factor: 4.600

7.  Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014.

Authors:  Joseph F Hayes; Louise Marston; Kate Walters; Michael B King; David P J Osborn
Journal:  Br J Psychiatry       Date:  2017-07-06       Impact factor: 9.319

8.  Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong - computerized data collection and analysis.

Authors:  Hok Sum Chan; Fanny Wai San Ko; Johnny Wai Man Chan; Loletta Kit Ying So; David Chi Leung Lam; Veronica Lee Chan; Cheuk Yin Tam; Wai Cho Yu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-13

9.  Cardiovascular outcomes associated with use of clarithromycin: population based study.

Authors:  Angel Y S Wong; Adrian Root; Ian J Douglas; Celine S L Chui; Esther W Chan; Yonas Ghebremichael-Weldeselassie; Chung-Wah Siu; Liam Smeeth; Ian C K Wong
Journal:  BMJ       Date:  2016-01-14

10.  Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.

Authors:  Kenneth K C Man; Esther W Chan; Patrick Ip; David Coghill; Emily Simonoff; Phyllis K L Chan; Wallis C Y Lau; Martijn J Schuemie; Miriam C J M Sturkenboom; Ian C K Wong
Journal:  BMJ       Date:  2017-05-31
View more
  4 in total

1.  Antipsychotic utilization patterns in pregnant women with psychotic disorders: a 16-year population-based cohort study.

Authors:  Jenny Wai Yiu Law; Joe Kwun Nam Chan; Corine Sau Man Wong; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-06       Impact factor: 5.270

2.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Severe Mental Illness: A Systematic Review and Meta-analysis.

Authors:  Joe Kwun Nam Chan; Ryan Sai Ting Chu; Chun Hung; Jenny Wai Yiu Law; Corine Sau Man Wong; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

3.  Educational attainment and mortality in schizophrenia.

Authors:  Martin Tesli; Eirik Degerud; Oleguer Plana-Ripoll; Kristin Gustavson; Fartein Ask Torvik; Eivind Ystrom; Helga Ask; Natalia Tesli; Anne Høye; Camilla Stoltenberg; Ted Reichborn-Kjennerud; Ragnar Nesvåg; Øyvind Naess
Journal:  Acta Psychiatr Scand       Date:  2022-02-18       Impact factor: 7.734

4.  The Impact of the COVID-19 Pandemic on the Lifestyles and Levels of Anxiety and Depression of Patients with Schizophrenia: A Retrospective Observational Study.

Authors:  Gemma Biviá-Roig; Pau Soldevila-Matías; Gonzalo Haro; Victor González-Ayuso; Francisco Arnau; Loreto Peyró-Gregori; Laura García-Garcés; Maria I Sánchez-López; Juan Francisco Lisón
Journal:  Healthcare (Basel)       Date:  2022-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.